Tempest Therapeutics

IPO

Targeted and Immune-Mediated Cancer Therapies

Public · Brisbane, United States · Founded 2011 · $85.0M raised

Employees
11–50
Founded
2011
Business Model
B2B
Total Funding
$85.0M
Last Round
$15.0M Private EquityApr 2022
Rounds
2
Type
Public

About

A clinical-stage oncology company advancing small molecules that combine both targeted and immune-mediated mechanisms with the potential to treat a wide range of tumors.

Summary

Tempest Therapeutics is a Biotech company based in Brisbane, United States, founded in 2011. It has raised $85.0M in total across 2 rounds, most recently a $15.0M Private Equity round in Apr 2022. Investors include Jerel Davis, EcoR1 Capital and F-Prime Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Private EquityPrivate PlacementApr 2022
$15.0M

Sign up to see all 2 rounds

Series B through Private Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tempest Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tempest-therapeutics"><img src="https://indexed.vc/api/badge/company/tempest-therapeutics" alt="Tempest Therapeutics on Indexed.vc" width="260" height="76" /></a>